COL6A3 and gastric cancer: The plasma level of COL6A3 had a sensitivity of 100% and a specificity of 46.2% to differentiate the GC patients from the healthy subjects, with an AUC of 0.720 at the optimal cut-off point (95% CI [0.522–0.919]).